COVID-19, Quercetin Phytosome, Anti-inflammatory, Immunomodulatory, Respiratory distress
Showing 1 - 25 of >10,000
COVID-19 Acute Respiratory Distress Syndrome, Viral Disease, Critical Illness Trial in Zagreb (Hemoperfusion)
Recruiting
- COVID-19 Acute Respiratory Distress Syndrome
- +5 more
- Hemoperfusion
-
Zagreb, Grad Zagreb, CroatiaUniversity Hospital Center Zagreb
Jul 22, 2022
Mechanisms for Organ Dysfunction in Covid-19
Recruiting
- COVID-19
- +5 more
-
Uppsala, SwedenUppsala University Hospital
May 26, 2022
Type I ANTi-Interferon Antibodies in COVID-19 Acute Respiratory
Completed
- Acute Respiratory Failure
-
Créteil, FranceAssistance Publique Hôpitaux de Paris - CHU HENRI MONDOR
Nov 8, 2021
COVID-19 Trial in Jamshoro (Standard COVID-19 care, Quercetin Phytosome)
Completed
- COVID-19
- Standard COVID-19 care
- Quercetin Phytosome
-
Jāmshoro, Sindh, PakistanLiaquat University Hospital
Apr 21, 2021
SARS-CoV 2 Trial in Paris (Inflammatory cytokines and chemokines profiles of patients with dexmedetomidine administration)
Recruiting
- SARS-CoV 2
- Inflammatory cytokines and chemokines profiles of patients with dexmedetomidine administration
-
Paris, FranceIntensive Care Unit and Respiratory division ; Groupe hospitalie
Jun 18, 2021
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Pneumonia Trial in United States (Tocilizumab)
Terminated
- Hematopoietic and Lymphoid Cell Neoplasm
- +5 more
- Tocilizumab
-
Rockville, Maryland
- +4 more
Jul 16, 2021
COVID, ARDS, Human, Ards Trial in Milano (IC14, a mAb against CD14)
No longer available
- COVID
- +3 more
- IC14, a monoclonal antibody against CD14
-
Milano, ItalyIRCCS San Raffaele Scientific Institute, Vita-Salute San Raffael
Jun 15, 2021
a Randomized Double-blind Study, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), PHYTOTHERAPIE Trial in Sahloul
Completed
- a Randomized Double-blind Study
- +2 more
-
Sahloul, Sousse, TunisiaRiadh Boukef
Jan 2, 2023
COVID 19 Biomarkers
Recruiting
- COVID 19
- serum inflammatory biomarkers
-
Vancouver, British Columbia, CanadaVancouver General Hospital
Oct 31, 2022
COVID-19 Trial in Lahore (standard of care for COVID-19 as per the hospital guidelines, Quercetin Phytosome (QP))
Completed
- COVID-19
- standard of care for COVID-19 as per the hospital guidelines
- Quercetin Phytosome (QP)
-
Lahore, Punjab, PakistanKing Edward Medical University Teaching Hospital
Jan 23, 2022
COVID-19 Trial in Cairo (drug, dietary supplement, other)
Completed
- COVID-19
- Colchicine 0.5 MG
- +2 more
-
Cairo, EgyptAin Shams University
Jun 21, 2023
Pulmonary Interstitial Emphysema in ARDS (PIE-ARDS)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Barotrauma
- Blood and bronchoalveolar fluid collection and analysis
- Chest CT scan
-
Cagliari, Italy
- +3 more
Aug 17, 2023
Rheumatic Diseases Trial in Portland (Hepatitis A vaccine, Diphtheria, pertussis, and tetanus booster vaccine)
Recruiting
- Rheumatic Diseases
- Hepatitis A vaccine
- Diphtheria, pertussis, and tetanus booster vaccine
-
Portland, OregonOregon Health & Science University
Sep 14, 2022
COVID-19 Pneumonia Trial in Valladolid (Mesenchymal Stromal Cells, Placebo)
Completed
- COVID-19 Pneumonia
- Mesenchymal Stromal Cells
- Placebo
-
Valladolid, SpainHospital Universitario Rio Hortega
Jun 6, 2022
Bronchoalveolar Lavage Trial in Mansoura (Bronchoalveolar Lavage)
Completed
- Bronchoalveolar Lavage
- Bronchoalveolar Lavage
-
Mansoura, EgyptMohamed AbdElmoniem
Aug 31, 2023
SARS (Severe Acute Respiratory Syndrome) Trial in Sousse, Sahloul (Quercetin, Placebo)
Completed
- SARS (Severe Acute Respiratory Syndrome)
- Quercetin
- Placebo
-
Sousse, Itinéraire Ceinture Cité Sahloul, Tunisia
- +1 more
Jan 2, 2023
Covid19, Pulmonary Fibrosis Interstitial Trial in Cairo (Colchicine 0.5 MG, the standard protocol only)
Active, not recruiting
- Covid19
- Pulmonary Fibrosis Interstitial
- Colchicine 0.5 MG
- the standard protocol only
-
Cairo, EgyptEl-Demerdash Hospital
Nov 6, 2022
Covid-19 Trial in Jamshoro (Complementary therapy, Standard of care)
Completed
- Covid-19
- Complementary therapy
- Standard of care
-
Jāmshoro, Sindh, PakistanLiaquat University Hospital
Mar 22, 2022
COVID-19 Trial in Assiut (Licorice extract)
Completed
- COVID-19
- Licorice extract
-
Assiut, EgyptFaculty of Medicine, Assiut University
Mar 21, 2022
COVID-19 Respiratory Infection Trial in Lublin (Xanthohumol - prenylated chalcone extracted from female inflorescences of hop
Suspended
- COVID-19 Respiratory Infection
- Xanthohumol - prenylated chalcone extracted from female inflorescences of hop cones (Humulus lupus). Hop-RXn™, BioActive-Tech Ltd, Lublin, Poland; http://xanthohumol.com.pl/
-
Lublin, PolandMedical University of Lublin
Jul 15, 2022
Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis Trial in Birmingham, Omaha (Upadacitinib, Abatacept, Secukinumab)
Recruiting
- Rheumatoid Arthritis
- +2 more
- Upadacitinib
- +7 more
-
Birmingham, Alabama
- +7 more
Sep 19, 2022
COVID-19 Trial in Lahore (Standard of care, Investigational treatment)
Completed
- COVID-19
- Standard of care
- Investigational treatment
-
Lahore, Punjab, PakistanKing Edward Medical University Teaching Hospital
Jan 13, 2022
COVID-19, SARS Trial in London (Control group, SLEDD with a L-MOD)
Recruiting
- COVID-19
- SARS
- Control group
- SLEDD with a L-MOD
-
London, Ontario, Canada
- +1 more
Apr 28, 2022